Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study.
Saved in:
| Title: | Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study. |
|---|---|
| Authors: | Adams, S1 (AUTHOR) sylvia.adams@nyumc.org, Loi, S2 (AUTHOR), Toppmeyer, D3 (AUTHOR), Cescon, D W4 (AUTHOR), Laurentiis, M De5 (AUTHOR), Nanda, R6 (AUTHOR), Winer, E P7 (AUTHOR), Mukai, H8 (AUTHOR), Tamura, K9 (AUTHOR), Armstrong, A10 (AUTHOR), Liu, M C11 (AUTHOR), Iwata, H12 (AUTHOR), Ryvo, L13 (AUTHOR), Wimberger, P14 (AUTHOR), Rugo, H S15 (AUTHOR), Tan, A R16 (AUTHOR), Jia, L17 (AUTHOR), Ding, Y17 (AUTHOR), Karantza, V17 (AUTHOR), Schmid, P18 (AUTHOR) |
| Source: | Annals of Oncology. Mar2019, Vol. 30 Issue 3, p405-411. 7p. 3 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 135688476 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Adams%2C+S%22">Adams, S</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> sylvia.adams@nyumc.org</i><br /><searchLink fieldCode="AR" term="%22Loi%2C+S%22">Loi, S</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Toppmeyer%2C+D%22">Toppmeyer, D</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cescon%2C+D+W%22">Cescon, D W</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Laurentiis%2C+M+De%22">Laurentiis, M De</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nanda%2C+R%22">Nanda, R</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Winer%2C+E+P%22">Winer, E P</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mukai%2C+H%22">Mukai, H</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tamura%2C+K%22">Tamura, K</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Armstrong%2C+A%22">Armstrong, A</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+M+C%22">Liu, M C</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Iwata%2C+H%22">Iwata, H</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ryvo%2C+L%22">Ryvo, L</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wimberger%2C+P%22">Wimberger, P</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rugo%2C+H+S%22">Rugo, H S</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tan%2C+A+R%22">Tan, A R</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jia%2C+L%22">Jia, L</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ding%2C+Y%22">Ding, Y</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Karantza%2C+V%22">Karantza, V</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmid%2C+P%22">Schmid, P</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Mar2019, Vol. 30 Issue 3, p405-411. 7p. 3 Charts, 1 Graph. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=135688476 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdy518 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 405 Titles: – TitleFull: Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Adams, S – PersonEntity: Name: NameFull: Loi, S – PersonEntity: Name: NameFull: Toppmeyer, D – PersonEntity: Name: NameFull: Cescon, D W – PersonEntity: Name: NameFull: Laurentiis, M De – PersonEntity: Name: NameFull: Nanda, R – PersonEntity: Name: NameFull: Winer, E P – PersonEntity: Name: NameFull: Mukai, H – PersonEntity: Name: NameFull: Tamura, K – PersonEntity: Name: NameFull: Armstrong, A – PersonEntity: Name: NameFull: Liu, M C – PersonEntity: Name: NameFull: Iwata, H – PersonEntity: Name: NameFull: Ryvo, L – PersonEntity: Name: NameFull: Wimberger, P – PersonEntity: Name: NameFull: Rugo, H S – PersonEntity: Name: NameFull: Tan, A R – PersonEntity: Name: NameFull: Jia, L – PersonEntity: Name: NameFull: Ding, Y – PersonEntity: Name: NameFull: Karantza, V – PersonEntity: Name: NameFull: Schmid, P IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 30 – Type: issue Value: 3 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |